PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.\', \'Department of Diabetes and Endocrinology, Salford Royal Hospital, Salford, UK.\', \'Oxford Centre for Diabetes, Endocrinology and Metabolism and NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS FT, Oxford, UK.\', \'Vernova Healthcare, Watersgreen Medical Centre, Macclesfield, UK.\', \'Clinical & Experimental Medicine, University of Surrey, Guildford, UK.\', \'Res Consortium, Andover, UK.\', \'Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/ijcp.14714
?:hasPublicationType
?:journal
  • International journal of clinical practice
is ?:pmid of
?:pmid
?:pmid
  • 34375490
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.892
?:rankingScore_hIndex
  • 84
is ?:relation_isRelatedTo_publication of
?:title
  • Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID-19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medication.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all